drugset / Trial / NCT03126422

Effects of Different Doses of Dexmedetomidine on Fentanyl-induced Cough

NCT03126422

Phase 1 Unknown 240 enrolled Yangzhou University
RandomizedFactorialDouble-blindTreatment

Summary

The investigators aimed to investigate the effects of pretreatment with different doses of dexmedetomidine on the cough caused by fentanyl during anesthetic induction. Patients undergoing elective surgeries under general anesthesia will be randomly allocated to 4 groups (n = 60, each group). Dexmedetomidine 0, 0.03, 0.06, and 0.09 μg/kg/min will be pump-administered in 10 mins to groups I, II, III, and IV, respectively, followed by the induction of general anesthesia with intravenous fentanyl 4 μg/kg. The incidences and severity of cough that occurred within 2 min after the injection of fentanyl will be recorded, and the incidences of cardiovascular adverse events that occurred between the administration of the dexmedetomidine infusion and 2 min after tracheal intubation will be recorded.

Timeline

Start
2017-05-01
Primary completion
2017-09-01
Completion
2017-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.6 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.9 ug/kg Intravenous

Indications

No indication recorded.